Clinical Trials Browser

Phase 2 × Various Advanced Cancer × Nivolumab × Clear all

NCT02387996 2022-11-01

A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

Phase 2 Completed

270 enrolled 14 charts

Various Advanced Cancer

NCT03130959 2022-08-09

CheckMate 908

Phase 2 Completed

166 enrolled 33 charts

Various Advanced Cancer